🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 8% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel(s) Serving Size
30 Servings
Other Combinations Product Type
8% Evidence Coverage

Supplement Facts — Evidence Check

Total Calories
26 Calorie(s)
Total Fat
2 g (3% DV)
Saturated Fat
(1% DV)
Trans Fat
Unsaturated Fat
1.8 g
Cholesterol
Total Carbohydrates
1 g (1% DV)
Protein
1.2 g (2% DV)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 2000mg UL 3000mg
500 mg
📊 Market median: 500.0mg (143 products)
This product: 500mg
1000 mg
📊 Market median: 17.4mg (161 products)
Median 17.4mg This product: 1000mg
500 mg
📊 Market median: 500.0mg (193 products) 📚 7 studies — no high-quality reviews
This product: 500mg

Other Ingredients

Fish Oil Concentrate Gelatin Leucine Glycerin Arginine Methionine, Powder Safflower Oil purified Water yellow Beeswax Carmine Dispersion Lecithin Titanium Dioxide

Label Claims — Verification

Nutrient
All Other
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years)

Product Information

📋 Directions for Use

Recommended Use: Take 2 softgels twice daily with meals.

🧪 Formulation Notes

Contains: Fish and Soybean

Additional Information

1. Nutrition 2001;17:751-755 2. British Journal of Cancer 91; 408-412, 2004 3. JEPonline. 7(1):48-56, 2004

4000mg Per Serving 30 Total Servings 5:1 EPA/DHA Ratio

{QR Code} Scan with your smart phone for EXCLUSIVE AST offers.

Made In USA

OMEGA-3 EPA-AMINO HYBRID BIOACTIVE

5:1 EPA-DHA ETHYL ESTER

Rev# MYOD413

ENGINEERED LIPID-AMINO ISOLATION TECHNOLOGY

Product Details

UPC / SKU 7 05077 00274 1
DSLD Entry Date 2013-05-24
Product Type Other Combinations
Form Softgel Capsule
DSLD ID 21458
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →